Effects of Vaccinium Berries on Serum Lipids: A Meta-Analysis of Randomized Controlled Trials

Evidence-based Complementary and Alternative Medicine

Volumn 2015, Issue , 2015, Pages

  Zhu, Yitong ^a   Miao, Ya ^a   Meng, Zheying ^a   Zhong, Yuan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHOCYANIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

BILBERRY; BLUEBERRY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CRANBERRY; DRUG EFFICACY; DRUG MECHANISM; HUMAN; LIPID BLOOD LEVEL; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TREATMENT DURATION; VACCINIUM;

EID: 84940380941     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2015/790329     Document Type: Review

References (49)

1. R. Lozano, M. Naghavi, K. Foreman et al., "Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010," The Lancet, vol. 380, no. 9859, pp. 2095-2128, 1990.
2. P.M. Ridker andN. R. Cook, "Statins: new American guidelines for prevention of cardiovascular disease," The Lancet, vol. 382, no. 9907, pp. 1762-1765, 2013.
3. S. Lewington, G. Whitlock, R. Clarke et al., "Blood cholesterol and vascular mortality by age, sex, and blood pressure: a metaanalysis of individual data from 61 prospective studies with 55,000 vascular deaths,"TheLancet, vol. 370, no. 9602, pp. 1829-1839, 2007.
4. A. M. Gotto Jr. and J. E. Moon, "Management of cardiovascular risk: the importance of meeting lipid targets," The American Journal of Cardiology, vol. 110, no. 1, pp. 3A-14A, 2012.
5. A. S. Wierzbicki, T. C. Hardman, and A. Viljoen, "New lipidlowering drugs: an update," International Journal of Clinical Practice, vol. 66, no. 3, pp. 270-280, 2012.
6. A. Moser and L. W. Segars, "Assessment of antihyperlipidemic therapy in US patients with coronary heart disease," Journal of theAmericanOsteopathic Association, vol. 110, no.6,pp. 331-339, 2010.
7. S. deDenus, S. A. Spinler, K. Miller, and A.M. Peterson, "Statins and liver toxicity: a meta-analysis," Pharmacotherapy, vol. 24, no. 5, pp. 584-591, 2004.
8. D. A. Taha, C. H. DeMoor, D. A. Barrett, and P. Gershkovich, "Translational insight into statin-inducedmuscle toxicity: from cell culture to clinical studies," Translational Research, vol. 164, no. 2, pp. 85-109, 2014.
9. J. S. Yoon and H. W. Lee, "Diabetogenic effect of statins: a double-edged sword?" Diabetes andMetabolismJournal, vol. 37, no. 6, pp. 415-422, 2013.
10. D. Preiss and N. Sattar, "Statins and the risk of new-onset diabetes: a review of recent evidence," Current Opinion in Lipidology, vol. 22, no. 6, pp. 460-466, 2011.
11. D. Bagchi, C. K. Sen, M. Bagchi, and M. Atalay, "Antiangiogenic, antioxidant, and anti-carcinogenic properties of a novel anthocyanin-rich berry extract formula," Biochemistry, vol. 69, no. 1, pp. 75-80, 2004.
12. D.-X. Hou, K. Kai, J.-J. Li et al., "Anthocyanidins inhibit activator protein 1 activity and cell transformation: structure-activity relationship and molecular mechanisms," Carcinogenesis, vol. 25, no. 1, pp. 29-36, 2004.
13. A. Lynn, S. Mathew, C. T. Moore et al., "Effect of a tart cherry juice supplement on arterial stiffness and inflammation in healthy adults: a randomised controlled trial," Plant Foods for Human Nutrition, vol. 69, no. 2, pp. 122-127, 2014.
14. R. Sasaki, N. Nishimura, H. Hoshino et al., "Cyanidin 3-glucoside ameliorates hyperglycemia and insulin sensitivity due to downregulation of retinol binding protein 4 expression in diabetic mice," Biochemical Pharmacology, vol. 74, no. 11, pp. 1619-1627, 2007.
15. Y. Zhu, X. Huang, Y. Zhang et al., "Anthocyanin supplementation improves HDL-associated paraoxonase 1 activity and enhances cholesterol efflux capacity in subjects with hypercholesterolemia," The Journal of Clinical Endocrinology & Metabolism, vol. 99, no. 2, pp. 561-569, 2014.
16. L. Titta, M. Trinei, M. Stendardo et al., "Blood orange juice inhibits fat accumulation in mice," International Journal of Obesity, vol. 34, no. 3, pp. 578-588, 2010.
17. P. Riso, F. Visioli, C. Gardana et al., "Effects of bloodorange juice intake on antioxidant bioavailability and on different markers related to oxidative stress," Journal of Agricultural and Food Chemistry, vol. 53, no. 4, pp. 941-947, 2005.
18. K. S. Shaughnessy, I. A. Boswall, A. P. Scanlan, K. T. Gottschall-Pass, and M. I. Sweeney, "Diets containing blueberry extract lower blood pressure in spontaneously hypertensive strokeprone rats," Nutrition Research, vol. 29, no. 2, pp. 130-138, 2009.
19. A. Z. Kalea, K. Clark, D. A. Schuschke, and D. J. Klimis-Zacas, "Vascular reactivity is affected by dietary consumption of wild blueberries in the sprague-dawley rat," Journal of Medicinal Food, vol. 12, no. 1, pp. 21-28, 2009.
20. R. L. Prior, X. Wu, L. Gu et al., "Purified berry anthocyanins but not whole berries normalize lipid parameters in mice fed an obesogenic high fat diet," Molecular Nutrition and Food Research, vol. 53, no. 11, pp. 1406-1418, 2009.
21. M. Leahy, J. Speroni, and M. Starr, "Latest developments in cranberry health research," Pharmaceutical Biology, vol. 40, supplement, pp. 50-54, 2002.
22. M. Y. Mahmoud, "Natural antioxidants effect of mulberry fruits (Morus nigra and Morus alba L.) on lipids profile and oxidative stress in hypercholestrolemic rats," Pakistan Journal of Nutrition, vol. 12, no. 7, pp. 665-672, 2013.
23. T. Wu, X. Qi, Y. Liu et al., "Dietary supplementation with purified mulberry (Morus australis Poir) anthocyanins suppresses body weight gain in high-fat diet fed C57BL/6 mice," Food Chemistry, vol. 141, no. 1, pp. 482-487, 2013.
24. D. Graf, S. Seifert, A. Jaudszus, A. Bub, and B. Watzl, "Anthocyanin-rich juice lowers serum cholesterol, leptin, and resistin and improves plasma fatty acid composition in fischer rats," PLoS ONE, vol. 8, no. 6,Article ID e66690, 2013.
25. Y. Qin, M. Xia, J. Ma et al., "Anthocyanin supplementation improves serum LDL-and HDL-cholesterol concentrations associated with the inhibition of cholesteryl ester transfer protein in dyslipidemic subjects," American Journal of Clinical Nutrition, vol. 90, no. 3, pp. 485-492, 2009.
26. J. P. T. Higgins and S. Green, Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0, The Cochrane Collaboration, London, UK, 2011.
27. The Cochrane Collaboration, Review Manager (RevMan). Version 5.1.6,The Nordic Cochrane Centre,The Cochrane Collaboration, Copenhagen, Denmark, 2011.
28. K. Valentová,D. Stejskal, P. Bedná?r et al., "Biosafety, antioxidant status, and metabolites in urine after consumption of dried cranberry juice in healthywomen: a pilot double-blind placebocontrolled trial," Journal of Agricultural andFoodChemistry, vol. 55, no. 8, pp. 3217-3224, 2007.
29. S. J. Duthie, A. M. Jenkinson, A. Crozier et al., "The effects of cranberry juice consumption on antioxidant status and biomarkers relating to heart disease and cancer in healthy human volunteers," European Journal of Nutrition, vol. 45, no. 2, pp. 113-122, 2006.
30. C.-K. Wang, H.-Y. Fu, and M. Chiang, "Cardiovascular disease prevention of cranberry vinegar," Nutritional Sciences Journal, vol. 32, no. 4, pp. 129-132, 2007.
31. I. T. Lee, Y. C. Chan, C. W. Lin, W. J. Lee, and W. H.-H. Sheu, "Effect of cranberry extracts on lipid profiles in subjects with Type 2 diabetes," Diabetic Medicine, vol. 25, no. 12, pp. 1473-1477, 2008.
32. A. Basu, N. M. Betts, J. Ortiz, B. Simmons, M. Wu, and T. J. Lyons, "Low-energy cranberry juice decreases lipid oxidation and increases plasma antioxidant capacity in women with metabolic syndrome," Nutrition Research, vol. 31, no. 3, pp. 190-196, 2011.
33. M. M. Dohadwala, M. Holbrook, N.M. Hamburg et al., "Effects of cranberry juice consumption on vascular function in patients with coronary artery disease,"The American Journal of Clinical Nutrition, vol. 93, no. 5, pp. 934-940, 2011.
34. A. J. Flammer, E. A. Martin, M. Gössl et al., "Polyphenol-rich cranberry juice has a neutral effect on endothelial function progenitor cells," European Journal of Nutrition, vol. 52, no. 1, pp. 289-296, 2013.
35. P. Riso, D. Klimis-Zacas,C. Del Bo' et al., "Effect of a wild blueberry (Vaccinium angustifolium) drink intervention onmarkers of oxidative stress, inflammation and endothelial function in humans with cardiovascular risk factors," European Journal of Nutrition, vol. 52, no. 3, pp. 949-961, 2013.
36. A. J. Stull, K. C. Cash, W. D. Johnson, C. M. Champagne, and W. T. Cefalu, "Bioactives in blueberries improve insulin sensitivity in obese, insulin-resistant men and women," Journal of Nutrition, vol. 140, no. 10, pp. 1764-1768, 2010.
37. A. Basu, M. Du, M. J. Leyva et al., "Blueberries decrease cardiovascular risk factors in obese men and women with metabolic syndrome," Journal of Nutrition, vol. 140, no. 9, pp. 1582-1587, 2010.
38. I. Erlund, R. Koli, G. Alfthan et al., "Favorable effects of berry consumption on platelet function, blood pressure, and HDL cholesterol,"The American Journal of Clinical Nutrition, vol. 87, no. 2, pp. 323-331, 2008.
39. Y. Zhu, W. Ling, H. Guo et al., "Anti-inflammatory effect of purified dietary anthocyanin in adults with hypercholesterolemia: a randomized controlled trial," Nutrition, Metabolism and Cardiovascular Diseases, vol. 23, no. 9, pp. 843-849, 2013.
40. M. Lankinen,M. Kolehmainen, T. Jaäskelaïnen et al., "Effects of whole grain, fish and bilberries on serum metabolic profile and lipid transfer protein activities: a randomized trial (Sysdimet)," PLoS ONE, vol. 9, no. 2,Article ID e90352, 2014.
41. S. Kianbakht, B. Abasi, and F. H. Dabaghian, "Improved lipid profile in hyperlipidemic patients taking Vaccinium arctostaphylos fruit hydroalcoholic extract: a randomized doubleblind placebo-controlled clinical trial," Phytotherapy Research, vol. 28, no. 3, pp. 432-436, 2014.
42. R. Soltani, M. Hakimi, S. Asgary, S. M. Ghanadian, M. Keshvari, and N. Sarrafzadegan, "Evaluation of the effects of Vaccinium arctostaphylos L. Fruit extract on serum lipids and hs-CRP levels and oxidative stress in adult patients with hyperlipidemia: a randomized, double-blind, placebo-controlled clinical trial," Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID217451, 6 pages, 2014.
43. C. B. Begg and M. Mazumdar, "Operating characteristics of a rank correlation test for publication bias," Biometrics, vol. 50, no. 4, pp. 1088-1101, 1994.
44. B. H. S. Lau, "Suppression of LDL oxidation by garlic compounds is a possible mechanism of cardiovascular health benefit," Journal of Nutrition, vol. 136, supplement 3, pp. 765S-768S, 2006.
45. T.K. McGhie, G. D. Ainge, L. E. Barnett, J. M. Cooney, andD. J. Jensen, "Anthocyanin glycosides from berry fruit are absorbed and excreted unmetabolized by both humans and rats," Journal of Agricultural and Food Chemistry, vol. 51, no. 16, pp. 4539-4548, 2003.
46. R. Ohnishi, H. Ito, N. Kasajima et al., "Urinary excretion of anthocyanins in humans after cranberry juice ingestion," Bioscience, Biotechnology and Biochemistry, vol. 70, no. 7, pp. 1681-1687, 2006.
47. R. G. Jepson, G. Williams, and J. C. Craig, "Cranberries for preventing urinary tract infections," Cochrane Database of Systematic Reviews, no. 10, Article IDCD001321, 2012.
48. A. C. Eke, S.N. Akarolo-Anthony, and A. P. Enumah, "Cranberries for treating asymptomatic bacteriuria during pregnancy," Cochrane Database of Systematic Reviews. In press.
49. R. G. Jepson and J.C. Craig, "Asystematic reviewof the evidence for cranberries and blueberries in UTI prevention," Molecular Nutrition and Food Research, vol. 51, no. 6, pp. 738-745, 2007.